Sage Therapeutics, Inc. Operating Lease, Liability, Current
Sage Therapeutics, Inc. had Operating Lease, Liability, Current of $1.88 million as of 2025-06-30, per its 10-Q filed 2025-07-30.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2025-07-30
- 2025-06-30: Operating Lease, Liability, Current $1.88M.
- 2025-03-31: Operating Lease, Liability, Current $1.81M.
- 2024-12-31: Operating Lease, Liability, Current $1.32M.
- 2024-09-30: Operating Lease, Liability, Current $83.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2025-06-30 | $1.88M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $1.81M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $1.32M 10-Q · filed 2025-07-30 |
| 2024-09-30 | $83.00K 10-Q · filed 2024-10-29 |
| 2024-06-30 | $1.41M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $3.31M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $5.17M 10-K · filed 2025-02-11 |
| 2023-09-30 | $6.97M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $7.72M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $7.68M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $7.64M 10-K · filed 2024-02-14 |
| 2022-09-30 | $7.60M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $7.56M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $7.52M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $7.47M 10-K · filed 2023-02-16 |
| 2021-09-30 | $7.41M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $7.36M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $7.31M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $8.66M 10-K · filed 2022-02-24 |
| 2020-09-30 | $8.62M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $8.58M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $10.27M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $10.24M 10-K · filed 2021-02-24 |
| 2019-09-30 | $7.56M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $7.39M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $7.15M 10-Q · filed 2019-05-02 |